The ideal therapy for a disease works exclusively at the site of the disease.But when it comes to the brain, which is wrapped in a protective barrier and contains thousands of different cell types, this ideal is very hard to achieve.Now, scientists a
Molecular GPS Developed to Direct Cell Therapies miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Researchers at Gladstone Institutes led by Senior Investigator Katerina Akassoglou, PhD, showed that exposure to blood leaking into the brain turns on harmful genes in microglia, transforming them into toxic cells that can destroy neurons.
/PRNewswire/ In patients with neurological diseases like Alzheimer s disease and multiple sclerosis, immune cells in the brain known as microglia that.
New Research Center to Tackle Brain Diseases
A unique combination of expertise at Gladstone Institutes and UC San Francisco will enable new therapies for Alzheimer s disease and multiple sclerosis
News provided by
Share this article
Share this article
SAN FRANCISCO, Jan. 28, 2021 /PRNewswire/ A team of scientists at Gladstone Institutes and UC San Francisco (UCSF) is launching the Gladstone-UCSF Center for Neurovascular Brain Immunology to study neurological diseases in a unique way that could lead to the development of novel treatments. This launch is supported by a $2.5-million donation from the Simon Family Trust.
Katerina Akassoglou will lead the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which brings together a unique combination of expertise to enable novel therapies for Alzheimer’s disease and multiple sclerosis.